Who is happy about the new home HD vs. PD survival study?
We bet that you can guess that NxStage is pretty excited about the terrific 5-year survival outcomes of home HD—especially since nocturnal HD (which is much more like the treatment done in Australia and New Zealand) has finally been approved in the US.
Read the full article » | Posted 07/08/2015
Related Articles
- Safe At Home Posted 01/09/2020
- Fresenius: Growth of Home Dialysis is NINE Times that of In-Center HD Posted 12/10/2019
- Fresenius TheHub is Three Connected Applications in One Posted 11/16/2019
- Outset Wins HHS Contract for Tablo HD System Use in Natural Disasters Posted 11/16/2019
- Outset Outshines! Posted 10/14/2019